• Gene deletion; HGNC; HGNC:583; APC; Zygosity=Homozygous (PubMed=12204677).
  
• Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=12204677; PubMed=17708598).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu257Arg (c.770T>G); ClinVar=VCV000142134; Zygosity=Heterozygous (PubMed=17708598).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; c.1100+30A>T; ClinVar=VCV000810938; Zygosity=Heterozygous (PubMed=17708598).
  

PubMed=12204677; DOI=10.1016/S0959-8049(02)00158-2
Richter M., Jurek D., Wrba F., Kaserer K., Wurzer G., Karner-Hanusch J., Marian B.
Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro.
Eur. J. Cancer 38:1937-1945(2002)

PubMed=12714179; DOI=10.1016/S0027-5107(03)00012-5
Schaeferhenrich A., Beyer-Sehlmeyer G., Festag G., Kuechler A., Haag N., Weise A., Liehr T., Claussen U., Marian B., Sendt W., Scheele J., Pool-Zobel B.L.
Human adenoma cells are highly susceptible to the genotoxic action of 4-hydroxy-2-nonenal.
Mutat. Res. 526:19-32(2003)

PubMed=17708598; DOI=10.1002/path.2220
Schulenburg A., Cech P., Herbacek I., Marian B., Wrba F., Valent P., Ulrich-Pur H.
CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2).
J. Pathol. 213:152-160(2007)

DOI=10.25365/thesis.6275
Koneczny I.
Investigating a model cell line for tumour stem cells in colorectal cancer.
Thesis MSc (2009); University of Vienna; Vienna; Austria

PubMed=27996158; DOI=10.1002/mc.22606
Schlormann W., Lamberty J., Lorkowski S., Ludwig D., Mothes H., Saupe C., Glei M.
Chemopreventive potential of in vitro fermented nuts in LT97 colon adenoma and primary epithelial colon cells.
Mol. Carcinog. 56:1461-1471(2017)